|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61P 27/02 | |||
| A61F 2/16 | |||
| A61K 47/34 |
| (11) | Number of the document | 2355795 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09799446.1 |
| Date of filing the European patent application | 2009-11-06 | |
| (97) | Date of publication of the European application | 2011-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/063490 |
| Date | 2009-11-06 |
| (87) | Number | WO 2010/056598 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 272548 | 2008-11-17 | US |
| (72) |
SPADA, Lon, T., US
GHEBREMESKEL, Alazar, N., US
ROBINSON, Michael, R., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | BIODEGRADABLE ALPHA-2 ADRENERGIC AGONIST POLYMERIC IMPLANTS |
| BIODEGRADABLE ALPHA-2 ADRENERGIC AGONIST POLYMERIC IMPLANTS |